Algae treatment for blindness scores $60M

John Gallagher reports in the Detroit Free Press that Ann Arbor, Michigan-based RetroSense Therapeutics, a small eye-care company that uses green algae genes to treat a type of human blindness, has sold for $60 million to Allergan, a $4 billion-a-year maker of skin and eye care products…